# Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-iii-trial-of-gefitinib-versus-docetaxel-in-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ki Hyeong Lee,Keunchil Park,Joo Hang Kim,Jong Seok Lee,Sang Won Shin,Jin Hyoung Kang,Myung‐Ju Ahn,Jin Seok Ahn,Cheolwon Suh,Sang-We Kim |
| Citations | 177 |
| DOI | 10.1158/1078-0432.ccr-09-1903 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/clincancerres/article-pdf/16/4/1307/1994325/1307.pdf |
| OpenAlex ID | https://openalex.org/W2118548009 |
| PMID | 20145166 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Jin Seok Ahn](https://scholariq.org/researchers/jin-seok-ahn-2/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.